Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
Tuyen T. Le, Joshua D. Di Vincenzo, Kayla M. Teopiz, Yena Lee, Danielle S. Cha, Leanna M.W. Lui, Nelson B. Rodrigues, Roger Ho, Bing Cao, Kangguang Lin, Flora Nasri, Hartej Gill, Orly Lipsitz, Mehala Subramaniapillai, Rodrigo B. Mansur, Joshua D. Rosenblat, Roger S. McIntyre
Topics & Concepts
PsychotomimeticPsychiatryElectroconvulsive therapyKetaminePsychotic depressionDepression (economics)PsychosisMedicinePsychologyAntidepressantTreatment-resistant depressionAntipsychoticMajor depressive disorderMoodSchizophrenia (object-oriented programming)Internal medicineNMDA receptorAnxietyMacroeconomicsEconomicsReceptorTreatment of Major DepressionTryptophan and brain disordersElectroconvulsive Therapy Studies